DE60206280D1 - Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia - Google Patents
Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopeniaInfo
- Publication number
- DE60206280D1 DE60206280D1 DE60206280T DE60206280T DE60206280D1 DE 60206280 D1 DE60206280 D1 DE 60206280D1 DE 60206280 T DE60206280 T DE 60206280T DE 60206280 T DE60206280 T DE 60206280T DE 60206280 D1 DE60206280 D1 DE 60206280D1
- Authority
- DE
- Germany
- Prior art keywords
- sarcopenia
- ginkgo biloba
- medicament
- extracts
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000001076 sarcopenia Diseases 0.000 title abstract 3
- 235000008100 Ginkgo biloba Nutrition 0.000 title abstract 2
- 244000194101 Ginkgo biloba Species 0.000 title abstract 2
- 239000000284 extract Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 abstract 2
- 229930184727 ginkgolide Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0109506A FR2827518B1 (fr) | 2001-07-17 | 2001-07-17 | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie |
| FR0109506 | 2001-07-17 | ||
| PCT/FR2002/002519 WO2003007973A1 (fr) | 2001-07-17 | 2002-07-16 | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60206280D1 true DE60206280D1 (de) | 2006-02-02 |
| DE60206280T2 DE60206280T2 (de) | 2006-07-27 |
Family
ID=8865590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60206280T Expired - Lifetime DE60206280T2 (de) | 2001-07-17 | 2002-07-16 | Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7138148B2 (de) |
| EP (1) | EP1411961B1 (de) |
| JP (1) | JP4510445B2 (de) |
| KR (1) | KR100891393B1 (de) |
| CN (1) | CN1272016C (de) |
| AT (1) | ATE304861T1 (de) |
| AU (1) | AU2002334001B2 (de) |
| CA (1) | CA2453254C (de) |
| DE (1) | DE60206280T2 (de) |
| DK (1) | DK1411961T3 (de) |
| ES (1) | ES2250726T3 (de) |
| FR (1) | FR2827518B1 (de) |
| HU (1) | HUP0400928A3 (de) |
| NZ (1) | NZ530367A (de) |
| PL (1) | PL202567B1 (de) |
| RU (1) | RU2298411C2 (de) |
| WO (1) | WO2003007973A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2842425B1 (fr) * | 2002-07-16 | 2005-04-08 | Sod Conseils Rech Applic | Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse |
| US8058211B2 (en) * | 2007-12-12 | 2011-11-15 | Halliburton Energy Services, Inc. | Corrosion inhibitor intensifier compositions and associated methods |
| US20120296403A1 (en) | 2010-02-10 | 2012-11-22 | Novartis Ag | Methods and compounds for muscle growth |
| JP6002503B2 (ja) | 2011-08-18 | 2016-10-05 | 株式会社半導体エネルギー研究所 | カルバゾール化合物 |
| KR102051433B1 (ko) | 2013-08-27 | 2020-01-08 | (주)네오팜 | 근육 분화 촉진 및 근육 강화용 조성물 및 외용제 |
| KR101771486B1 (ko) | 2015-06-25 | 2017-08-25 | 서울대학교산학협력단 | 특정 다마란 계열의 성분이 증가된 인삼추출물의 제조방법 및 이를 이용한 근육감소증 관련 질환 치료용 조성물 |
| KR102281263B1 (ko) | 2019-03-12 | 2021-07-26 | 주식회사 비티씨 | 갈릭산, 에피카테킨(ec), 및 에피갈로카테킨(egc)의 함량이 증가된 카테킨 효소처리물 및 이의 제조방법 |
| JP2022534471A (ja) | 2019-05-31 | 2022-08-01 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 動物における健康効果を提供するためのｍｃｔベースの栄養ブレンド |
| KR102229177B1 (ko) | 2019-12-27 | 2021-03-18 | 부산대학교 산학협력단 | 로즈마리 추출물 및 대두 추출물을 유효성분으로 함유하는 근육 감소증 예방 또는 치료용 조성물 |
| KR20240133112A (ko) | 2023-02-28 | 2024-09-04 | 주식회사 건강중심주의 | 근육 감소 관련 질환의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3338995A1 (de) * | 1983-10-27 | 1985-05-09 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Bilobalid enthaltende arzneimittel |
| US5002965A (en) * | 1989-05-09 | 1991-03-26 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Use of ginkgolides to prevent reperfusion injury in organ transplantation |
| AU3582597A (en) * | 1996-06-28 | 1998-01-21 | Viva America Marketing, Inc. | Nutritional supplement composition and use |
| FR2763592B1 (fr) * | 1997-05-20 | 1999-07-16 | Sod Conseils Rech Applic | Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant |
| JP3293524B2 (ja) * | 1997-06-17 | 2002-06-17 | 有限会社薬研 | イチョウ葉抽出エキス担持粉体複合物及びその製造方法 |
| FR2771639B1 (fr) * | 1997-12-03 | 2000-05-05 | Sod Conseils Rech Applic | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction |
| US6030621A (en) * | 1998-03-19 | 2000-02-29 | De Long; Xie | Ginkgo biloba composition, method to prepare the same and uses thereof |
| BR9910329A (pt) * | 1998-05-11 | 2001-01-30 | Novo Nordisk As | Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto |
| RU2141320C1 (ru) * | 1998-07-14 | 1999-11-20 | Научно-исследовательский институт фармакологии Томского научного центра РАМН | Гемореологическое средство |
| FR2782008B1 (fr) * | 1998-08-07 | 2003-04-25 | Sod Conseils Rech Applic | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique |
-
2001
- 2001-07-17 FR FR0109506A patent/FR2827518B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-16 AU AU2002334001A patent/AU2002334001B2/en not_active Ceased
- 2002-07-16 AT AT02787156T patent/ATE304861T1/de active
- 2002-07-16 HU HU0400928A patent/HUP0400928A3/hu unknown
- 2002-07-16 RU RU2004104463/15A patent/RU2298411C2/ru not_active IP Right Cessation
- 2002-07-16 KR KR1020047000669A patent/KR100891393B1/ko not_active Expired - Fee Related
- 2002-07-16 NZ NZ530367A patent/NZ530367A/en not_active IP Right Cessation
- 2002-07-16 WO PCT/FR2002/002519 patent/WO2003007973A1/fr active IP Right Grant
- 2002-07-16 DE DE60206280T patent/DE60206280T2/de not_active Expired - Lifetime
- 2002-07-16 PL PL367089A patent/PL202567B1/pl unknown
- 2002-07-16 US US10/481,953 patent/US7138148B2/en not_active Expired - Fee Related
- 2002-07-16 ES ES02787156T patent/ES2250726T3/es not_active Expired - Lifetime
- 2002-07-16 CN CNB028143663A patent/CN1272016C/zh not_active Expired - Fee Related
- 2002-07-16 CA CA2453254A patent/CA2453254C/fr not_active Expired - Fee Related
- 2002-07-16 EP EP02787156A patent/EP1411961B1/de not_active Expired - Lifetime
- 2002-07-16 DK DK02787156T patent/DK1411961T3/da active
- 2002-07-16 JP JP2003513578A patent/JP4510445B2/ja not_active Expired - Fee Related
-
2006
- 2006-01-12 US US11/330,767 patent/US7232580B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2827518B1 (fr) | 2005-07-08 |
| HUP0400928A3 (en) | 2008-04-28 |
| EP1411961A1 (de) | 2004-04-28 |
| FR2827518A1 (fr) | 2003-01-24 |
| KR100891393B1 (ko) | 2009-04-02 |
| CA2453254A1 (fr) | 2003-01-30 |
| RU2298411C2 (ru) | 2007-05-10 |
| NZ530367A (en) | 2006-05-26 |
| ATE304861T1 (de) | 2005-10-15 |
| KR20040013150A (ko) | 2004-02-11 |
| JP2005512956A (ja) | 2005-05-12 |
| PL202567B1 (pl) | 2009-07-31 |
| US7232580B2 (en) | 2007-06-19 |
| RU2004104463A (ru) | 2005-06-10 |
| CA2453254C (fr) | 2011-02-15 |
| HUP0400928A1 (hu) | 2004-07-28 |
| PL367089A1 (en) | 2005-02-21 |
| ES2250726T3 (es) | 2006-04-16 |
| WO2003007973A1 (fr) | 2003-01-30 |
| US7138148B2 (en) | 2006-11-21 |
| CN1272016C (zh) | 2006-08-30 |
| HK1069327A1 (en) | 2005-05-20 |
| EP1411961B1 (de) | 2005-09-21 |
| DE60206280T2 (de) | 2006-07-27 |
| US20060121135A1 (en) | 2006-06-08 |
| US20040166180A1 (en) | 2004-08-26 |
| JP4510445B2 (ja) | 2010-07-21 |
| CN1533281A (zh) | 2004-09-29 |
| AU2002334001B2 (en) | 2007-07-19 |
| DK1411961T3 (da) | 2006-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
| DE60135755D1 (de) | Verbindungen und methoden zur behandlung von hautverletzungen | |
| WO2004091540A3 (en) | Methods of treating pain and compositions for use therefor | |
| DE69921662D1 (de) | Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose | |
| DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| DE60206280D1 (de) | Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia | |
| WO2005011572A3 (en) | Combination of drugs for the treatment of neoplasms | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| ATE448788T1 (de) | Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen | |
| ATE410172T1 (de) | Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE294582T1 (de) | Verwendung von alpha-1-adrenorezeptor- antagonisten zur herstellung eines medikaments für die vorbeugung und die behandlung von krebs | |
| DE69622704D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von alkoholsucht | |
| DE60335892D1 (de) | Pharmazeutische zusammensetzung zur herstellung eines medikaments zur behandlung und/oder vorbeugung und/oder fettleibigkeit im zusammenhang steht | |
| UA67795C2 (uk) | Склад для лікування опікових ран, який включає мірамістин | |
| ATE382347T1 (de) | Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol | |
| ATE460168T1 (de) | Nicht-radioaktives strontiummittel zur behandlung von krebs | |
| DE69312297D1 (de) | Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs | |
| ATE466587T1 (de) | Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe | |
| ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| ATE450267T1 (de) | Verwendung von ginkgo biloba extrakten zur förderung der muskelmasse zum nachteil der fettmasse | |
| DE69516602D1 (de) | Verwendung von Bifemelan zur Herstellung eines Arzneimittels zur Behandlung der Hyperkinesie | |
| DE50002999D1 (de) | Verwendung von extrakten aus ginkgo-biloba-blättern zur behandlung von schlafstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: IPSEN PHARMA S.A.S., BOULOGNE-BILLANCOURT, FR |